Oncogenic transcription factors as splicing regulators;Des oncogènes à l'interface entre transcription et épissage

Medecine/Sciences

Volumn 20, Issue 11, 2004, Pages 1014-1019

  Théoleyre, Orianne ^a   Baklouti, Faouzi ^a  

^a CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MESSENGER RNA; RNA POLYMERASE II; TRANSCRIPTION FACTOR;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; DRUG DESIGN; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE INSERTION; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; ONCOGENE; POINT MUTATION; PROGNOSIS; PROVIRUS; REVIEW; RNA SPLICING; SIGNAL TRANSDUCTION; TUMOR GROWTH;

INSERTION SEQUENCES;

EID: 8544279604     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200420111014     Document Type: Review

References (28)

1. Gisselbrecht S. Oncogenes and leukemia: history and perspectives. Med Sci (Paris) 2003; 19: 201-10.
2. Boyd KE, Farnham PJ. Identification of target genes of oncogenic transcription factors. Proc Soc Exp Biol Med 1999; 222: 9-28.
3. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059-64.
4. Dittmer J, Nordheim A. Ets transcription factors and human disease. Biochim Biophys Acta 1998; 1377: F1-11.
5. Galiana-Arnoux D, Lejeune F, Gesnel MC, et al. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20. J Biol Chem 2003; 278: 32943-53.
6. Caballero OL, de Souza SJ, Brentani RR, Simpson AJ. Alternative spliced transcripts as cancer markers. Dis Markers 2001; 17: 67-75.
7. Knoop LL, Baker SJ. The splicing factor UIC represses EWS/FLI-mediated transactivation. J Biol Chem 2000; 275: 24865-71.
8. Poleev A, Hartmann A, Stamm S. A trans-acting factor, isolated by the three-hybrid system, that influences alternative splicing of the amyloid precursor protein minigene. Eur J Biochem 2000; 267: 4002-10.
9. Yang L, Embree LJ, Hickstein DD. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol Cell Biol 2000; 20: 3345-54.
10. Knoop LL, Baker SJ. EWS/FLI alters 5′-splice site selection. J Biol Chem 2001; 276: 22317-22.
11. Yang L, Chansky HA, Hickstein DD. EWS. Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing. J Biol Chem 2000; 275: 37612-8.
12. Chansky HA, Hu M, Hickstein DD, Yang L. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res 2001; 61: 3586-90.
13. Moreau-Gachelin F, Wendling F, Molina T, et al. Spi1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol 1996; 16: 2453-63.
14. Starck J, Doubeikovski A, Sarrazin S, et al. Spi1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines. Mol Cell Biol 1999; 19: 121-35.
15. Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 2002; 21: 3368-76.
16. Hallier M, Tavitian A, Moreau-Gachelin F. The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrb. J Biol Chem 1996; 271: 11177-81.
17. Hallier M, Lerga A, Barnache S, et al. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J Biol Chem 1998; 273: 4838-42.
18. Deguillien M, Huang SC, Marinière M, et al. Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation. Blood 2001; 98: 3809-16.
19. Théoleyre O, Deguillien M, Morinière M, et al. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells. Oncogene 2004; 23: 920-7.
20. Orphanides G, Reinberg D. A unified theory of gene expression. Cell 2002; 108: 439-51.
21. Nogues G, Kadener S, Cramer P, et al. Transcriptional activators differ in their abilities to control alternative splicing. J Biol Chem 2002; 277: 43110-4.
22. Kadener S, Fededa JP, Rosbash M, Kornblihtt AR. Regulation of alternative splicing by a transcriptional enhancer through RNA pol II elongation. Proc Natl Acad Sci USA 2002; 99: 8185-90.
23. Furger A, O'Sullivan JM, Binnie A, et al. Promoter proximal splice sites enhance transcription. Genes Dev 2002; 16: 2792-9.
24. Kwek KY, Murphy S, Furger A, et al. U1 snRNA associates with TFIIH and regulates transcriptional initiation. Nat Struct Biol 2002; 9: 800-5.
25. Ge H, Si Y, Wolffe AP. A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. Mol Cell 1998; 2: 751-9.
26. Fong YW, Zhou Q. Stimulatory effect of splicing factors on transcriptional elongation. Nature 2001; 414: 929-33.
27. Tian H. RNA ligands generated against complex nuclear targets indicate a role for U1 snRNP in coordinating transcription and RNA splicing. FEBS Lett 2001; 509: 282-6.
28. Lai MC, Teh BH, Tarn WY. A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing. J Biol Chem 1999; 274: 11832-41.